Cargando…

A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays

BACKGROUND: Bringing reliable and accurate tuberculosis (TB) diagnosis closer to patients is a key priority for global TB control. Molbio Diagnostics have developed the Truenat point-of-care molecular assays for detection of TB and rifampicin (RIF) resistance. METHODS: We conducted a prospective mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penn-Nicholson, Adam, Gomathi, Sivaramakrishnan N., Ugarte-Gil, Cesar, Meaza, Abyot, Lavu, Evelyn, Patel, Pranav, Choudhury, Bandana, Rodrigues, Camilla, Chadha, Sarabjit, Kazi, Mubin, Macé, Aurélien, Nabeta, Pamela, Boehme, Catharina, Gangakhedkar, Raman R., Sarin, Sanjay, Tesfaye, Ephrem, Gotuzzo, Eduardo, du Cros, Philipp, Tripathy, Srikanth, Ruhwald, Morten, Singh, Manjula, Denkinger, Claudia M., Schumacher, Samuel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607906/ https://www.ncbi.nlm.nih.gov/pubmed/34049948 http://dx.doi.org/10.1183/13993003.00526-2021

Ejemplares similares

Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia
por: Meaza, Abyot, et al.
Publicado: (2021)

Rapid Diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach
por: Nikam, Chaitali, et al.
Publicado: (2013)

Multicentric validation of indigenous molecular test Truenat™ MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards
por: Gomathi, N.S., et al.
Publicado: (2020)

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
por: Lee, David J., et al.
Publicado: (2019)

2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector
por: Lee, David J, et al.
Publicado: (2018)

Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah
por: Yadav, Pragya D., et al.
Publicado: (2021)

Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
por: Ruhwald, Morten, et al.
Publicado: (2022)

Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019
por: Basawarajappa, Shantala Gowdara, et al.
Publicado: (2021)

Truenat® for Plasmodium sub-microscopic infections: Miles to go…
por: Deora, Nimita, et al.
Publicado: (2022)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Comparative Analysis of Results of RT-PCR and Truenat in diagnosis of Covid 19
por: Sharma, Mamta, et al.
Publicado: (2021)

Tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert(®) MTB/RIF Ultra and Molbio Truenat(®) MTB Ultima
por: Wood, Rachel C., et al.
Publicado: (2023)

Truenat™ - micro real-time-polymerase chain reaction for rapid diagnosis of leptospirosis at minimal resource settings
por: Rajamani, M., et al.
Publicado: (2021)

Truenat: An affordable and user-friendly option for screening of sub-microscopic Plasmodium infections in low resource countries
por: Shankar, Hari, et al.
Publicado: (2022)

A Comparative study of RT-PCR and TRUENAT BETA-CoV TEST in a tertiary care hospital
por: Pagidirai, Sandhya rani, et al.
Publicado: (2021)

Diagnostic tools used in the evaluation of acute febrile illness in South India: a scoping review
por: Bhaskaran, Divyalakshmi, et al.
Publicado: (2019)

Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon
por: Ngangue, Yannick Russel, et al.
Publicado: (2022)

Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India
por: Gopalaswamy, Radha, et al.
Publicado: (2023)

Upfront Xpert MTB/RIF for diagnosis of pediatric TB—Does it work? Experience from India
por: Kalra, Aakshi, et al.
Publicado: (2020)

Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis
por: Nabeta, Pamela, et al.
Publicado: (2017)

Assessing a chip based rapid RTPCR test for SARS CoV-2 detection (TrueNat assay): A diagnostic accuracy study
por: Ghoshal, Ujjala, et al.
Publicado: (2021)

Tuberculosis among refugees and migrant populations: Systematic review
por: Meaza, Abyot, et al.
Publicado: (2022)

Performance characteristics and operational feasibility assessment of a CRISPR based tata MD CHECK diagnostic test for SARS-CoV-2 (COVID-19)
por: Shenai, Shubhada, et al.
Publicado: (2023)

Phage lysin to control the overgrowth of normal flora in processed sputum samples for the rapid and sensitive detection of Mycobacterium tuberculosis by luciferase reporter phage assay
por: Subramanyam, Balaji, et al.
Publicado: (2013)

Is Knowledge Regarding Tuberculosis Associated with Stigmatising and Discriminating Attitudes of General Population towards Tuberculosis Patients? Findings from a Community Based Survey in 30 Districts of India
por: Sagili, Karuna D., et al.
Publicado: (2016)

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape
por: Hamada, Yohhei, et al.
Publicado: (2022)

Simultaneous screening for COVID-19 and tuberculosis, India
por: Duppala, Keertana, et al.
Publicado: (2023)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
por: Gomathi, N.S., et al.
Publicado: (2020)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Molecular typing and drug sensitivity profiles of M. Tuberculosis isolated from refugees residing in Ethiopia
por: Meaza, Abyot, et al.
Publicado: (2023)

Implementation of a tuberculosis elimination project, India 2018–2019
por: Kalra, Aakshi, et al.
Publicado: (2023)

Serial survey shows community intervention may contribute to increase in knowledge of Tuberculosis in 30 districts of India
por: Thapa, Badri, et al.
Publicado: (2016)

Laser-assisted permanent greenfield filter removal with ileocaval stent reconstruction following filter thrombosis, a case report
por: Kaur, Sarabjit, et al.
Publicado: (2023)

“Before Xpert I only had my expertise”: A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities
por: McDowell, Andrew, et al.
Publicado: (2018)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB
por: Bashir, Saima, et al.
Publicado: (2022)

Enhancing the role of private practitioners in tuberculosis prevention and care activities in India
por: Anand, Tanu, et al.
Publicado: (2017)

Integrated testing for TB and COVID-19
por: MacLean, Emily L., et al.
Publicado: (2022)

Prevalence of tuberculosis and associated factors among presumptive TB refugees residing in refugee camps in Ethiopia
por: Meaza, Abyot, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ufk0t6olp8s8s2p7kclp9ppph